December
2007 – USP revises and releases General Chapter Pharmaceutical
Compounding – Sterile Preparations <797> to Tighten Patient
Safety Guidance
The U.S. Pharmacopeia announced
that changes to General Chapter Pharmaceutical Compounding – Sterile
Preparations <797> have been finalized and available online. This
revision improves patient safety by tightening standards and conditions
for sterile compounding over the current version of USP <797>.
The full chapter
is available FREE OF CHARGE by going to the USP website
below:
http://www.usp.org/USPNF/pf/generalchapter797.html
These
revisions were posted to give the compounding community time to implement
changes before they become official. These revisions become official
on June 1, 2008 and will be included in USP 32 – NF 27 and the
second edition of the Pharmacists’ Pharmacopeia which will be
published in March 2008. After June 1, 2008, the current version of
USP 31 – NF 26 will no longer be the official chapter.
NIOSH
SAFETY ALERT
NIOSH has issued a Safety Alert
for Preventing Occupational Exposure to Antineoplastic and other Hazardous
Drugs in Healthcare Settings. For additional information: http://www.cdc.gov/niosh/topics/hazdrug/
CETA Certification
Guide for Sterile Compounding Facilities CAG-003-2006
On June 7, 2006, the Controlled Environment Testing Association (CETA)
has published and released the "CETA Certification Guide for Sterile
Compounding Facilities". As an active supporter in CETA, Micro-Clean
personnel aided in the review and research process of this important
document.
"This guide is to establish an industry-based
minimum set of criteria appropriate for performance evaluation and certification
of facility and environmental controls used for compounding sterile
preparations. It is intended to assist compounders, facilities managers
and certification professionals in determining appropriate tests and
procedures to be employed on the various engineering controls. This
guideline has been established to create a uniform approach for field
certifiers to allow consistent and repeatable testing at all facilities."
This document is available through
http://www.cetainternational.org.
CETA COMPOUNDING
ISOLATOR TESTING GUIDE CAG-002-2006
The Controlled Environment Testing Association (CETA)
has published and released the “CETA Isolator Testing Guide”
(CAG-002-2006). As an active member in CETA, Micro-Clean personnel were
intimately involved in the test procedure development, interacting with
isolator manufacturers, research support, and review process of this
document.
This document provides Compounding Aseptic
Isolator users and owners recommended tests that should be provided
by the manufacturer of their isolator – thereby verifying that
their isolator should meet the sterility and/or containment needs as
required in USP Chapter 797 and the 2004 NIOSH Safety Alert “Preventing
Occupational Exposures to Antineoplastic and Other Hazardous Drugs in
Health Care Settings”.
The purpose of this document is to establish
an industry-based minimum set of testing criteria appropriate for all
Compounding Isolators used pursuant to USP Chapter 797. Compounding
Isolators consist of Compounding Aseptic Isolators used for compounding
sterile preparations and Compounding Aseptic Containment Isolators used
for compounding sterile hazardous drug preparations in pharmacy applications.
It is the manufacturer’s responsibility to determine exact testing
procedures consistent with these guidelines and assign appropriate values
pertaining to acceptance criteria that is consistent with user requirements.
This guide has also been established to create a uniform approach for
field certifiers to allow consistent and repeatable testing at all facilities.
NEW ISOLATOR
APPLICATIONS GUIDE FROM CETA The Controlled Environment
Testing Association (CETA) has published and released the
“CETA Applications Guide for the use of Compounding
Isolators in Compounding Sterile Preparations in Healthcare Facilities”
(CAG-001-2005). As an active member in CETA, Micro-Clean personnel were
involved in the development, support, and review process of this document.
This document is paramount for pharmacists interested in employing Compounding
Isolator technology in their Aseptic Compounding practices as part of
obtaining or maintaining compliance with USP <797> “Pharmaceutical
Compounding – Sterile Preparations”. This document is available
through http://www.cetainternational.org.
UPDATE ON NEW AND REVISED
IEST DOCUMENTS
"As very active participants in the IEST Working Groups
001, 019, 023 034 (and several more), Micro-Clean is proud to announce
that several new publications have been released for publication. These
Recommended Practices are published by the Institute of Environmental
Sciences and Technology to advance engineering and technical sciences
relating to Contamination Control."
These Recommended Practices are available through www.iest.org.
IEST-RP-CC034.2
“HEPA and ULPA Filter Leak Test” ("Required reading"
for pharmaceutical and biotechnology organizations)
This expanded Recommended Practice covers definitions,
equipment, and procedures for leak testing HEPA and ULPA filters in
the factory, at the job site before installation, and as-installed in
cleanrooms and in unidirectional-flow, clean-air devices. The document
also includes guidelines for selecting the appropriate leak-test method
and procedures for measuring the uniformity of the aerosol challenge
approaching the filter under test.
IEST-RP-CC001.4 “HEPA
AND ULPA FILTERS”
This document covers the basic provisions for HEPA and
ULPA filter units for applications requiring extremely high filter efficiency
(99.97% or higher) for submicrometer particles. The RP provides performance
information for 11 filter types, defines six construction grades, and
includes a handy Filter Selection Guide that lists typical applications
for each filter type.
IEST-RP-CC019.1 “QUALIFICATIONS
FOR ORGANIZATIONS ENGAGED IN THE TESTING AND CERTIFICATION OF CLEANROOMS
AND CLEAN-AIR DEVICES”
This Recommended Practice defines recommended qualifications
for organizations engaged in the testing and certification of cleanrooms,
clean-air devices, HEPA- and ULPA-filtered systems, and associated components.
The document also establishes professional categories for personnel
performing testing and levels of competence to be demonstrated by the
personnel.
IEST-RP-CC023.2: MICROORGANISMS
IN CLEANROOMS
This Recommended Practice provides guidelines for the
control and quantitative measurement of viable contamination in the
air and on surfaces in environments that require control of such contamination.
This includes areas designated as aseptic and those considered non sterile.
The procedures and techniques employed to achieve the desired level
of microbial control are dependent on the level of bioburden that can
be tolerated. This RP presents an introduction to the currently accepted
methods for bioburden control and environmental monitoring as well as
the devices available for the quantification of airborne and surface
viable contamination.
This document also describes disinfectants, their
lethality spectrum, and techniques for their application.
Animal
Lab News
CASE
STUDY:
Chlorine
Dioxide Gas Decontamination of the University of Pennsylvania’s
George D. Widener Large Animal Hospital Intensive and Neonatal Care
Units
Case Study, Mark A. Czarneski, Paul Lorcheim, Thomas Boyle, Helen Aceto,
Barbara Dallap, Donald Munro, Michael A. Regits, and Henry S. Luftman,
May/June 2005
"After a salmonellosis outbreak,
the 170,000 cubic foot C. Mahlon Kline building remained under quarantine
until a successful decontamination program was implemented...
The decontamination process using chlorine dioxide gas was determined
to be an unqualified success. Swab tests for Salmonella taken for two
months post decontamination produced no positives. The University of
Pennsylvania’s C. Mahlon Kline Intensive and Neonatal Care Units
was lifted from quarantine and declared fully operational."